tiprankstipranks
CTI BioPharma Corp. (GB:0RLB)
LSE:0RLB

CTI BioPharma (0RLB) Stock Investors

0 Followers
Based on 661,832 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0RLB
On average, investors allocate 4.94% of their portfolios to GB:0RLB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0RLB

1.6%
Last 7
Days
4.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0RLB, out of 661,832 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0RLB Investor Activity

No data currently available
Based on the activity of 12,370 investors who made their portfolios public
The table shows changes in 0RLB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0RLB Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Syros Pharmaceuticals
3.68%
-0.95%
-5.77%
61.99M
Healthcare
Blink Charging Co
4.01%
+0.23%
+2.02%
398.04M
Utilities
Moderna
5.41%
-0.07%
+0.07%
45.31B
Healthcare
Nikola
5.73%
-0.02%
+2.70%
1.01B
Energy
Mullen Automotive
4.23%
+0.84%
-1.05%
123.46M
Industrials
General Electric
5.59%
>-0.01%
-0.81%
117.90B
Industrials
DraftKings
6.25%
-0.34%
-0.09%
22.78B
Technology
Plug Power
4.67%
+0.31%
+3.16%
6.37B
Energy
ChargePoint Holdings
4.91%
-0.43%
+0.68%
3.06B
Technology
Enphase Energy
5.01%
+0.49%
+5.14%
22.77B
Energy
Based on the activity of 661,832 active portfolios
Open your Smart Portfolio

0RLB Investor Analysis

GB:0RLB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.7%
of GB:0RLB holders
are under 35
Average Segment Performance
Average P/E Ratio35.74
Beta11.13
Dividend Yield4.33%
GB:0RLB investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
54.7%
of GB:0RLB holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.85
Beta14.34
Dividend Yield4.58%
GB:0RLB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
34.7%
of GB:0RLB holders
are over 55
Average Segment Performance
Average P/E Ratio37.66
Beta5.41
Dividend Yield4.64%
Overview of age group and performance of GB:0RLB stock investors
See who invests in 0RLB according to age group and performance.

FAQ

How many retail Investors hold GB:0RLB?
<0.1% of TipRanks' retail investors hold GB:0RLB in their portfolios.
    What is GB:0RLB Investor Sentiment?
    GB:0RLB’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0RLB in the last 7 days?
      ▼ 1.6% of TipRanks' retail investors changed their holding of GB:0RLB in the last 7 days.
        What percentage of retail investors changed their holding of GB:0RLB in the last 30 days?
        ▼ 4.9% of TipRanks' retail investors changed their holding of GB:0RLB in the last 30 days.
          What is the average age of retail investors who hold GB:0RLB?
          The average age of GB:0RLB Holders is between 35–55.
            What other stocks have GB:0RLB investors also bought?
            GB:0RLB Investors also bought SYRS, BLNK, MRNA, NKLA, MULN, GE, DKNG, PLUG, CHPT, ENPH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ATECAlphatec Holdings
              AZNAstraZeneca
              BLRXBioline RX Ltd Sponsored ADR
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis